A study of mice using an OSCC model showed that TEX could suppress tumor immune response by inhibiting proliferation of both CD4+ and CD8+ T cells and reducing infiltration of T cells into tumors, thereby promoting the carcinogenesis of murine oral squamous cell carcinomas (172). Here, CD8A is linked to neoplasm.